These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9633229)

  • 1. [Exanthema in multiple therapy in HIV infection].
    Weisser M
    Praxis (Bern 1994); 1998 May; 87(20):702-4. PubMed ID: 9633229
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim-sulphamethoxazole rechallenge in 20 previously allergic HIV-infected patients after homeopathic.
    Bissuel F; Cotte L; Crapanne JB; Rougier P; Schlienger I; Trepo C
    AIDS; 1995 Apr; 9(4):407-8. PubMed ID: 7794554
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
    Maserati R; Villani P; Cocchi L; Regazzi MB
    AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 5. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Le Moal G; Breux JP; Roblot F
    N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding prophylactic therapy for HIV infections.
    Anastasi JK; Rivera J
    Am J Nurs; 1994 Feb; 94(2):36-41; quiz 42. PubMed ID: 8304396
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV: opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Jun; (9):795-816. PubMed ID: 15366175
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa?
    Samb B; Badiane M; Kony S; Larouzé B; Faye MA; Sow PS; Badiane S; Metro A; Costagliola D; Ndoye I; Delaporte E; Coll-Seck AM; Coulaud JP
    AIDS; 1998 Mar; 12(4):447. PubMed ID: 9520181
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 11. Polypharmacy: dangers of multiple-drug therapy in patients with immunodeficiency virus infection.
    Ungvarski P; Schmidt J
    Home Healthc Nurse; 1993; 11(2):68-9. PubMed ID: 8478201
    [No Abstract]   [Full Text] [Related]  

  • 12. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization.
    Kardaun SH; de Waard MM; de Monchy JG
    Contact Dermatitis; 2009 Jul; 61(1):50-1. PubMed ID: 19659967
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-trimoxazole desensitization syndrome: delayed hematologic toxicity complicating prophylactic therapy in AIDS patients.
    Stricker RB; Gullett JH; Williams LE; Goldberg B
    AIDS; 1996 Jul; 10(8):927-9. PubMed ID: 8828756
    [No Abstract]   [Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Graham SM
    Bull World Health Organ; 2004 Apr; 82(4):297-8. PubMed ID: 15259259
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
    Mueller BU; Pizzo PA
    Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
    [No Abstract]   [Full Text] [Related]  

  • 16. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
    ;
    Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumocystis jiroveci pneumonia in AIDS patients: reactivation, reinfection or both?
    Hudson CP; Roach TC
    Int J STD AIDS; 2003 Sep; 14(9):644-5. PubMed ID: 14511507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebral toxoplasmosis in HIV infected patients intolerant of cotrimoxazole].
    Rabaud C; May T; Beuscart C; Reynes J; Leport C; Canton P
    Ann Med Interne (Paris); 1998 Mar; 149(2):62-6. PubMed ID: 11490526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection.
    Gill CJ; Sabin LL; Tham J; Hamer DH
    Bull World Health Organ; 2004 Apr; 82(4):290-7. PubMed ID: 15259258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Pneumocystis carinii prophylaxis still need to be lifelong?
    Masur H; Kaplan J
    N Engl J Med; 1999 Apr; 340(17):1356-8. PubMed ID: 10219072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.